Cerebrovascular disease in ageing and Alzheimer’s disease

Por Love, Seth, Miners, J. Scott
Publicado no Acta Neuropathol (2015)

Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzh...

Por Miners, J Scott, Schulz, Isabel, Love, Seth
Publicado no J Cereb Blood Flow Metab (2017)

Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease

Por Miners, J. Scott, Palmer, Jennifer C., Love, Seth
Publicado no Brain Pathol (2015)

Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1

Por Miners, J Scott, Renfrew, Ruth, Swirski, Marta, Love, Seth
Publicado no Acta Neuropathol Commun (2014)

The influence of tumour necrosis factor- α (TNF-α) on amyloid-β (Aβ)-degrading enzymes in vitro

Por Culpan, Doris, Palmer, Jennifer, Miners, J Scott, Love, Seth, Kehoe, Patrick G
Publicado em 2011

ACE variants and association with brain Aβ levels in Alzheimer's disease

Por Miners, J Scott, van Helmond, Zoë, Raiker, Merryn, Love, Seth, Kehoe, Patrick G
Publicado em 2010

Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology

Por Kehoe, Patrick Gavin, Wong, Steffenny, AL Mulhim, Noura, Palmer, Laura Elyse, Miners, J. Scott
Publicado no Alzheimers Res Ther (2016)

Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes

Por Miners, J. Scott, Palmer, Jennifer C., Tayler, Hannah, Palmer, Laura E., Ashby, Emma, Kehoe, Patrick G., Love, Seth
Publicado em 2014

Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease

Por Swirski, Marta, Miners, J Scott, de Silva, Rohan, Lashley, Tammaryn, Ling, Helen, Holton, Janice, Revesz, Tamas, Love, Seth
Publicado no Alzheimers Res Ther (2014)

Inhibition of Coxsackie B Virus Infection by Soluble Forms of Its Receptors: Binding Affinities, Altered Particle Formation, and Competition with Cellular Receptors

Por Goodfellow, Ian G., Evans, David J., Blom, Anna M., Kerrigan, Dave, Miners, J. Scott, Morgan, B. Paul, Spiller, O. Brad
Publicado em 2005

Prion Protein Is Decreased in Alzheimer's Brain and Inversely Correlates with BACE1 Activity, Amyloid-β Levels and Braak Stage

Por Whitehouse, Isobel J., Miners, J. Scott, Glennon, Elizabeth B. C., Kehoe, Patrick G., Love, Seth, Kellett, Katherine A. B., Hooper, Nigel M.
Publicado em 2013

BIN1 Is Decreased in Sporadic but Not Familial Alzheimer’s Disease or in Aging

Por Glennon, Elizabeth B. C., Whitehouse, Isobel J., Miners, J. Scott, Kehoe, Patrick G., Love, Seth, Kellett, Katherine A. B., Hooper, Nigel M.
Publicado em 2013

Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's disease

Por Ferrington, Linda, Miners, J Scott, Palmer, Laura E, Bond, Susan M, Povey, Joanne E, Kelly, Paul AT, Love, Seth, Horsburgh, Karen J, Kehoe, Patrick G
Publicado em 2011